Cite
Effect of the guideline education program on anticholinergic and benzodiazepine use in outpatients with schizophrenia and major depressive disorder: The effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE) project
MLA
Hirotaka Yamagata, et al. “Effect of the Guideline Education Program on Anticholinergic and Benzodiazepine Use in Outpatients with Schizophrenia and Major Depressive Disorder: The Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) Project.” Psychiatry Research Communications, vol. 4, no. 1, Mar. 2024. EBSCOhost, https://doi.org/10.1016/j.psycom.2024.100158.
APA
Hirotaka Yamagata, Yuko Fujii, Shinichiro Ochi, Tomoe Seki, Naomi Hasegawa, Hisashi Yamada, Hikaru Hori, Kayo Ichihashi, Jun-ichi Iga, Kazuyoshi Ogasawara, Naoki Hashimoto, Hitoshi Iida, Kazutaka Ohi, Takashi Tsuboi, Shusuke Numata, Akitoyo Hishimoto, Masahide Usami, Eiichi Katsumoto, Hiroyuki Muraoka, … Ryota Hashimoto. (2024). Effect of the guideline education program on anticholinergic and benzodiazepine use in outpatients with schizophrenia and major depressive disorder: The effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE) project. Psychiatry Research Communications, 4(1). https://doi.org/10.1016/j.psycom.2024.100158
Chicago
Hirotaka Yamagata, Yuko Fujii, Shinichiro Ochi, Tomoe Seki, Naomi Hasegawa, Hisashi Yamada, Hikaru Hori, et al. 2024. “Effect of the Guideline Education Program on Anticholinergic and Benzodiazepine Use in Outpatients with Schizophrenia and Major Depressive Disorder: The Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) Project.” Psychiatry Research Communications 4 (1). doi:10.1016/j.psycom.2024.100158.